{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:06:52Z","timestamp":1785413212075,"version":"3.56.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011022","name":"Vertex Pharmaceuticals Incorporated","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011022","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jcf.2026.03.016","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T20:43:54Z","timestamp":1774989834000},"page":"682-688","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of Elexacaftor\/Tezacaftor\/Ivacaftor on cough frequency, physical activity patterns, and sleep quality in adolescents and adults with cystic fibrosis"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7242-0747","authenticated-orcid":false,"given":"Eva","family":"Van Braeckel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4214-6350","authenticated-orcid":false,"given":"Andrew T.","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1705-4780","authenticated-orcid":false,"given":"Nicholas J.","family":"Simmonds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane C.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie E.","family":"Egan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1593-210X","authenticated-orcid":false,"given":"Allen","family":"Lapey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4057-2199","authenticated-orcid":false,"given":"Marcus A.","family":"Mall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward F.","family":"McKone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7723-1868","authenticated-orcid":false,"given":"Daniel","family":"Peckham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5576-9517","authenticated-orcid":false,"given":"Marijke","family":"Proesmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie","family":"Ramsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2082-8983","authenticated-orcid":false,"given":"Saioa Vicente","family":"Santamaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Taylor-Cousar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Tullis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4070-1023","authenticated-orcid":false,"given":"Elke","family":"De Wachter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5326-0258","authenticated-orcid":false,"given":"Nick","family":"Withers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Ahluwalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Conner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4098-780X","authenticated-orcid":false,"given":"Yiyue","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8448-7453","authenticated-orcid":false,"given":"Tanya G.","family":"Weinstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6150-6927","authenticated-orcid":false,"given":"Dominic","family":"Keating","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2026.03.016_bib0001","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/S0140-6736(16)00576-6","article-title":"Cystic fibrosis","volume":"388","author":"Elborn","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jcf.2026.03.016_bib0002","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2213-2600(19)30337-6","article-title":"The future of cystic fibrosis care: a global perspective","volume":"8","author":"Bell","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jcf.2026.03.016_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2017.09.003","article-title":"Progress in understanding mucus abnormalities in cystic fibrosis airways","volume":"17","author":"Wine","year":"2018","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.03.016_bib0004","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jpainsymman.2007.06.005","article-title":"Self-reported physical and psychological symptom burden in adults with cystic fibrosis","volume":"35","author":"Sawicki","year":"2008","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jcf.2026.03.016_bib0005","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/S0140-6736(23)01608-2","article-title":"The future of cystic fibrosis treatment: from disease mechanisms to novel therapeutic approaches","volume":"402","author":"Graeber","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jcf.2026.03.016_bib0006","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1183\/09031936.00224911","article-title":"Quality of life and healthcare utilisation in cystic fibrosis: a multicentre study","volume":"41","author":"Bradley","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2026.03.016_bib0007","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1186\/s12890-023-02701-3","article-title":"Current cough and sputum assessed by the cough and sputum assessment-questionnaire (CASA-Q) is associated with quality of life impairment in cystic fibrosis","volume":"23","author":"Charon","year":"2023","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jcf.2026.03.016_bib0008","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1159\/000512268","article-title":"Mucin secretion in Cystic Fibrosis: a systematic review","volume":"39","author":"Niv","year":"2021","journal-title":"Dig Dis"},{"key":"10.1016\/j.jcf.2026.03.016_bib0009","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jcf.2011.02.003","article-title":"Ambulatory quantitative waking and sleeping cough assessment in patients with cystic fibrosis","volume":"10","author":"Kerem","year":"2011","journal-title":"J Cyst Fibros"},{"issue":"Suppl 1","key":"10.1016\/j.jcf.2026.03.016_bib0010","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jcf.2014.03.009","article-title":"European cystic fibrosis society standards of care: framework for the Cystic Fibrosis centre","volume":"13","author":"Conway","year":"2014","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.03.016_bib0011","doi-asserted-by":"crossref","first-page":"500","DOI":"10.4187\/respcare.07193","article-title":"Mermis JD. Physical activity level and perception of exercise in cystic fibrosis","volume":"65","author":"Burnett","year":"2020","journal-title":"Respir Care"},{"key":"10.1016\/j.jcf.2026.03.016_bib0012","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1183\/09031936.00091607","article-title":"Skeletal muscle weakness, exercise tolerance and physical activity in adults with cystic fibrosis","volume":"33","author":"Troosters","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2026.03.016_bib0013","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jcf.2023.05.005","article-title":"Characterization of sleep in emerging adults with cystic fibrosis on elexacaftor\/tezacaftor\/ivacaftor","volume":"23","author":"Meltzer","year":"2024","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.03.016_bib0014","doi-asserted-by":"crossref","DOI":"10.3390\/nu13092907","article-title":"The impact of highly effective CFTR modulators on growth and nutrition status","volume":"13","author":"Bass","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.jcf.2026.03.016_bib0015","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1056\/NEJMoa1709846","article-title":"Tezacaftor-Ivacaftor in patients with cystic fibrosis homozygous for Phe508del","volume":"377","author":"Taylor-Cousar","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2026.03.016_bib0016","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with a single Phe508del allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2026.03.016_bib0017","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial","volume":"394","author":"Heijerman","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jcf.2026.03.016_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2023.03.002","article-title":"Real-world safety and effectiveness of elexacaftor\/tezacaftor\/ivacaftor in people with cystic fibrosis: interim results of a long-term registry-based study","author":"Bower","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.03.016_bib0019","first-page":"PA2101","article-title":"The impact of Symkevi (Tezacaftor\/Ivacaftor) on exercise capacity in adolescents with CF","volume":"58","author":"Ahmed","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2026.03.016_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e26729","article-title":"One year effect of tezacaftor and ivacaftor on functional exercise capacity and muscle strength in people with cystic fibrosis","volume":"10","author":"Anne-Sophie","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.jcf.2026.03.016_bib0021","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1002\/ppul.26078","article-title":"Elexacaftor-Tezacaftor-Ivacaftor improves exercise capacity in adolescents with cystic fibrosis","volume":"57","author":"Causer","year":"2022","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2026.03.016_bib0022","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.sleep.2017.01.014","article-title":"Validation of the epworth sleepiness scale for children and adolescents using rasch analysis","volume":"33","author":"Janssen","year":"2017","journal-title":"Sleep Med"},{"key":"10.1016\/j.jcf.2026.03.016_bib0023","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.smrv.2013.08.002","article-title":"Evaluation of the measurement properties of the Epworth sleepiness scale: a systematic review","volume":"18","author":"Kendzerska","year":"2014","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.jcf.2026.03.016_bib0024","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.smrv.2015.01.009","article-title":"The Pittsburgh sleep quality index as a screening tool for sleep dysfunction in clinical and non-clinical samples: a systematic review and meta-analysis","volume":"25","author":"Mollayeva","year":"2016","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.jcf.2026.03.016_bib0025","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.4187\/respcare.03290","article-title":"Cough characteristics and FVC maneuver in cystic fibrosis","volume":"59","author":"Vilozni","year":"2014","journal-title":"Respir Care"},{"key":"10.1016\/j.jcf.2026.03.016_bib0026","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.pedn.2022.02.013","article-title":"Cough in adolescent with cystic fibrosis, from nightmare to COVID-19 stigma: a qualitative thematic analysis","volume":"64","author":"Taheri","year":"2022","journal-title":"J Pediatr Nurs"},{"key":"10.1016\/j.jcf.2026.03.016_bib0027","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1183\/09031936.00089312","article-title":"Cough frequency in health and disease","volume":"41","author":"Yousaf","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2026.03.016_bib0028","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00408-017-0038-x","article-title":"The Objective assessment of cough frequency in bronchiectasis","volume":"195","author":"Spinou","year":"2017","journal-title":"Lung"},{"key":"10.1016\/j.jcf.2026.03.016_bib0029","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jcf.2023.10.010","article-title":"Effect of elexacaftor\/tezacaftor\/ivacaftor on mucus and mucociliary clearance in cystic fibrosis","volume":"23","author":"Donaldson","year":"2024","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.03.016_bib0030","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1164\/rccm.202201-0219OC","article-title":"Effects of Elexacaftor\/Tezacaftor\/Ivacaftor therapy on lung clearance index and Magnetic resonance imaging in patients with cystic fibrosis and one or two F508del alleles","volume":"206","author":"Graeber","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2026.03.016_bib0031","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12890-015-0151-7","article-title":"Relationship between pulmonary exacerbations and daily physical activity in adults with cystic fibrosis","volume":"15","author":"Savi","year":"2015","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jcf.2026.03.016_bib0032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154587","article-title":"The minimal important difference in physical activity in patients with COPD","volume":"11","author":"Demeyer","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jcf.2026.03.016_bib0033","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02084-2017","article-title":"Next generation of anti-inflammatory therapy for COPD?","volume":"50","author":"Watz","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2026.03.016_bib0034","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1093\/eurheartj\/ehab580","article-title":"Physical activity and fitness in the community: the Framingham Heart Study","volume":"42","author":"Nayor","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcf.2026.03.016_bib0035","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2165\/00007256-200131020-00002","article-title":"Challenges and opportunities for measuring physical activity in sedentary adults","volume":"31","author":"Tudor-Locke","year":"2001","journal-title":"Sports Med"},{"key":"10.1016\/j.jcf.2026.03.016_bib0036","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jcf.2011.12.002","article-title":"Feasibility of using pedometers to measure daily step counts in cystic fibrosis and an assessment of its responsiveness to changes in health state","volume":"11","author":"Quon","year":"2012","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.03.016_bib0037","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jshs.2022.10.003","article-title":"Exercise sustains the hallmarks of health","volume":"12","author":"Qiu","year":"2023","journal-title":"J Sport Health Sci"},{"key":"10.1016\/j.jcf.2026.03.016_bib0038","first-page":"31","article-title":"Physical activity and its correlates in people with cystic fibrosis: a systematic review","author":"Kinaupenne","year":"2022","journal-title":"Eur Respir Rev"},{"issue":"56 Suppl 1","key":"10.1016\/j.jcf.2026.03.016_bib0039","first-page":"S23","article-title":"Sleep-disordered breathing in cystic fibrosis","author":"Jagpal","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2026.03.016_bib0040","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/resp.12719","article-title":"Physical activity participation by adults with cystic fibrosis: an observational study","volume":"21","author":"Cox","year":"2016","journal-title":"Respirology"},{"key":"10.1016\/j.jcf.2026.03.016_bib0041","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.4187\/respcare.03665","article-title":"Dalcin pde T. Relationship between clinical variables and health-related quality of life in young adult subjects with cystic fibrosis","volume":"60","author":"Forte","year":"2015","journal-title":"Respir Care"},{"key":"10.1016\/j.jcf.2026.03.016_bib0042","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/MCP.0000000000001014","article-title":"Neuropsychiatric adverse effects from CFTR modulators deserve a serious research effort","volume":"29","author":"VanElzakker","year":"2023","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.jcf.2026.03.016_bib0043","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/ppul.25285","article-title":"Cystic fibrosis patients of minority race and ethnicity less likely eligible for CFTR modulators based on CFTR genotype","volume":"56","author":"McGarry","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2026.03.016_bib0044","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.cpcardiol.2018.11.002","article-title":"Increasing diversity in clinical trials: overcoming critical barriers","volume":"44","author":"Clark","year":"2019","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.jcf.2026.03.016_bib0045","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1017\/cts.2022.510","article-title":"Barriers to and solutions for representative inclusion across the lifespan and in life course research: the need for structural competency highlighted by the COVID-19 pandemic","volume":"7","author":"LeCroy","year":"2023","journal-title":"J Clin Transl Sci"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199326000834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199326000834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:30:45Z","timestamp":1785411045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199326000834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1569199326000834"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2026.03.016","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Elexacaftor\/Tezacaftor\/Ivacaftor on cough frequency, physical activity patterns, and sleep quality in adolescents and adults with cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2026.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}